Hilyard K L, Reyburn H, Chung S, Bell J I, Strominger J L
Department of Biochemistry and Molecular Biology, Harvard University, Cambridge, MA 02138.
Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9057-61. doi: 10.1073/pnas.91.19.9057.
An Escherichia coli expression system has been developed to produce milligram quantities of the variable domains of a human T-cell receptor from a cytotoxic T cell that recognizes the HLA-A2-influenza matrix peptide complex as a single polypeptide chain. The recombinant protein was purified by metal-chelate chromatography and then refolded in a redox buffer system. The refolded protein was shown to directly bind both Staphylococcus aureus enterotoxin B and the major histocompatibility complex protein-peptide complex using a BIAcore biosensor. Thus this preparation of a single-chain, variable-domain, T-cell receptor fragment can bind both of its natural ligands and some of it is therefore a functional fragment of the receptor molecule.
已开发出一种大肠杆菌表达系统,用于从细胞毒性T细胞中生产毫克量的人T细胞受体可变域,该细胞毒性T细胞将HLA - A2 - 流感基质肽复合物识别为单条多肽链。重组蛋白通过金属螯合层析进行纯化,然后在氧化还原缓冲系统中复性。使用BIAcore生物传感器显示,复性后的蛋白能直接结合金黄色葡萄球菌肠毒素B和主要组织相容性复合体蛋白 - 肽复合物。因此,这种单链可变域T细胞受体片段制剂能结合其两种天然配体,所以其中一些是受体分子的功能片段。